within the rapidly evolving industry of cancer therapeutics, being familiar with the intricate mechanisms of Antibody-Drug Conjugates (ADCs) is important for developing effective remedies. Among the most promising ways is the usage of in vitro bystander outcome assays, which Participate in a pivotal job in improving therapeutic efficacy. These assa